Frank C Tinsley

Title: Frank C. Tinsley: Innovator in Neuropeptide Y Research

Introduction

Frank C. Tinsley is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of neuropeptide research, particularly in developing methods to treat conditions associated with neuropeptide Y. With a total of 3 patents to his name, Tinsley's work has the potential to impact the treatment of obesity and related disorders.

Latest Patents

Tinsley's latest patents focus on innovative methods for treating neuropeptide Y-associated conditions. One of his inventions describes methods that involve administering an analog of an obesity protein to treat conditions linked to an excess of neuropeptide Y. This invention also highlights the combination of this analog with a neuropeptide Y antagonist, demonstrating that the obesity protein can reduce the production of neuropeptide Y by the hypothalamus. Another patent reiterates similar methods, emphasizing the administration of an obesity protein alone or in combination with a neuropeptide Y antagonist to address these conditions.

Career Highlights

Frank C. Tinsley is associated with Eli Lilly and Company, where he continues to advance his research and innovations. His work at this prominent pharmaceutical company allows him to collaborate with other experts in the field and contribute to groundbreaking developments in medical treatments.

Collaborations

Tinsley has worked alongside talented colleagues, including Juliana Maude Bue-Valleskey and Mark Louis Heiman. Their collaborative efforts enhance the research environment and foster innovation in neuropeptide studies.

Conclusion

Frank C. Tinsley's contributions to neuropeptide Y research exemplify the impact of innovative thinking in medicine. His patents and work at Eli Lilly and Company highlight the importance of collaboration and dedication in advancing healthcare solutions.